Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending February 15, 2008. The report details a specific corporate action regarding the repurchase and cancellation of the company's own ordinary shares, executed under authority granted by shareholders at the Annual General Meeting on May 23, 2007.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share buyback transaction:
- Shares Purchased: 2,700,000 ordinary shares of 25 pence each.
- Purchase Price: 1,115.3923 pence per share.
- Treasury Shares Held: 504,194,158 shares (representing 9.18% of total voting rights).
- Shares in Issue: 5,494,818,857 shares (excluding Treasury shares).
Material Changes
The primary material change reported is the reduction of the company's share capital through the cancellation of 2,700,000 shares. Consequently, the number of shares held in Treasury has increased to 504,194,158. The filing does not provide comparative data against a prior period for operational or financial performance.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It strictly serves as a notification of the share repurchase and cancellation in conformity with the Financial Services Authority's Disclosure and Transparency Rules. The document explicitly states it does not constitute an offer or solicitation to purchase securities.
Key Facts for Investor Verification
- Verify the total cost of the buyback by multiplying 2,700,000 shares by the price of 1,115.3923 pence.
- Confirm the updated total voting rights denominator (5,494,818,857 shares) for calculating disclosure thresholds under FSA rules.
- Note that the Treasury shareholding now represents 9.18% of total voting rights.
- Recognize that this filing does not contain quarterly or annual financial performance data.